Mark A. Socinski

36.4k citations
518 papers · 22.3k indexed · 12 hit papers · h-index 69

Impact in

  • Oncology top 0.02%
    • Lung Cancer Research Studies
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Lung Cancer Research Studies 196
    • Colorectal Cancer Treatments and Studies 96
    • Cancer Immunotherapy and Biomarkers 73
    • Cancer Treatment and Pharmacology 49
    • Lung Cancer Treatments and Mutations 408
    • Lung Cancer Diagnosis and Treatment 146

Mark A. Socinski

505 papers receiving 21.8k citations

Hit Papers

Association of Immune-Related Adverse Events With Efficacy of Atezolizumab in Patients With Non–Small Cell Lung Cancer 2023 · 102 citations
102198820262000201350010001.5k2.0k2.5k

Peers

Mark A. Socinski
Comparison fields: 5 of 155
  • Oncology 15.1k
  • Pulmonary and Respiratory Medicine 14.6k
  • Cancer Research 3.0k
  • Immunology 1.7k
  • Radiation 684
Replace Chandra P. Belani with:
Chandra P. Belani United States
Johan Vansteenkiste Belgium
David R. Gandara United States
Jaffer A. Ajani United States
Giorgio V. Scagliotti Italy
Solange Peters Switzerland
Byoung Chul Cho South Korea
Harry J.M. Groen Netherlands
Suresh S. Ramalingam United States
Thierry Le Chevalier France
Mark A. Socinski relative to Chandra P. Belani United States Chandra P. Belani's profile →
Citations per field
00.5×
Chandra P. Belani · 1×
Citations per year

Countries citing papers authored by Mark A. Socinski

Since Specialization
Citations

This map shows the geographic impact of Mark A. Socinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Socinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Socinski more than expected).

Fields of papers citing papers by Mark A. Socinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Socinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Socinski. The network helps show where Mark A. Socinski may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark A. Socinski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. Socinski Line = papers co-authored together Mark A. Socinski links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20243
3 202421
4 20241
5 202334
6 20237
7 20232
8 202325
9 20232
10 202313
11 202313
12 20233
13 20212
14 20208
15 201777
16
Efficacy and safety of necitumumab continuation therapy in phase 3 SQUIRE study
20151
17 2012192
18 2010194
19
Biomarker Associations With Survival for Refractory NSCLC Patients Receiving Erlotinib +/- Sunitinib in a Randomized Phase 2 Trial
20101
20
Performans Statusu 2 Olan ve İleri Evre Küçük Hücreli Dışı Akciğer Kanseri Olgularında Kombinasyona Karşı Tek Ajan Kemoterapisi İki Büyük Randomize Klinik Çalışma Çerçevesinde Prognostik Faktörler ve Tedavi Seçimi
20091

About Mark A. Socinski

Mark A. Socinski is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Hepatology and Otorhinolaryngology, having authored 518 papers that have together received 22.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (408 papers), Lung Cancer Research Studies (196 papers), Lung Cancer Diagnosis and Treatment (146 papers), Colorectal Cancer Treatments and Studies (96 papers), Cancer Immunotherapy and Biomarkers (73 papers), Cancer Genomics and Diagnostics (59 papers), Cancer Treatment and Pharmacology (49 papers) and Cancer therapeutics and mechanisms (38 papers). The work is most often cited by research in Oncology (15.1k citations), Pulmonary and Respiratory Medicine (14.6k citations), Cancer Research (3.0k citations), Immunology (1.7k citations) and Radiation (684 citations). Mark A. Socinski has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Thomas E. Stinchcombe, Martin Reck, Robert M. Jotte, Liza C. Villaruz, Federico Cappuzzo, Fabrice Barlési, Delvys Rodríguez‐Abreu, Daniil Stroyakovskiy, Francesco Orlandi and Alan Sandler. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, Lung Cancer and Clinical Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026